← Evidence map

ArticleCancers2020

PKM2 Expression as Biomarker for Resistance to Oxaliplatin-Based Chemotherapy in Colorectal Cancer.

Maria Sfakianaki et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

20 papers cite it

2020
2021
2022
2023
2024
2025
2026
this papercites it
Full record →Abstract, authors, funding and every citing paper · PMID 32722474